HIGH

American Health Packaging Recalls Chlorpromazine Tablets Due to Contamination Risk

American Health Packaging recalled 873 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the presence of a micro-organism in packaging material. No micro-organisms were found on the tablets themselves.

Quick Facts at a Glance

Recall Date
August 27, 2025
Hazard Level
HIGH
Brands
CHLORPROMAZINE HYDROCHLORIDE, American Health Packaging
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled product includes Chlorpromazine Hydrochloride Tablets, USP, 200 mg, distributed in 100-count blister packs. The affected lot numbers are 1021640 (expiring on 10/31/2026) and 1022639 (expiring on 01/31/2027).

The Hazard

The recall involves a specific lot of auxiliary polyester coil used in packaging, which tested positive for a micro-organism. This poses a potential health risk, classified as Class II by the FDA.

Reported Incidents

No micro-organisms have been detected on the tablets themselves. There are no reported incidents of illness or injury related to this recall.

What to Do

Consumers and healthcare providers should stop using the recalled product immediately. Contact Amerisource Health Services LLC or consult your healthcare provider for further guidance.

Contact Information

For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0650-2025 or contact Amerisource Health Services LLC.

Key Facts

  • Recalled product: Chlorpromazine Hydrochloride Tablets, USP, 200 mg
  • Quantity: 873 cartons
  • Recall date: August 27, 2025
  • No micro-organisms detected on tablets
  • Immediate stop-use advisory issued

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot: 1021640
Lot: 1022639
UPC Codes
60687-419
60687-430
60687-441
+12 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more